November in Review

Spotlight on FDA-Approved Optune Device to Treat Glioblastoma
The Optune device is a portable FDA-Approved device designated to treat glioblastoma (GBM). GBM is an aggressive tumor that forms in the tissue of the brain and spinal cord, according to the American Brain Tumor Association. Today, GBM is increasingly common. With Senator John McCain recently being diagnosis with having glioblastoma, this disease has been the topic of discussion, more now than ever. Dr. Simon Khagi is the director of the UNC Brain Tumor Program and is using the Optune device to treat his patients. According to Dr. Khagi, the state of North Carolina has 500 GBM cases per year. I was recently granted a brief opportunity to talk with Dr. Khagi and ask a few questions about the device and how it is being used to help his patients at UNC (Click on the title of the article to read the interview and learn more).
UNC Cancer Network Release New Learning Portal Website with Free CE Courses!
The UNC Cancer Network is excited to announce the release of a new website. The UNC Cancer Network Learning Portal (https://learn.unccn.org) is the new home to free and open-access online oncology education courses. (Click on the title to read entire article and learn more).
Special Online Oral Cancer Lecture on December 8, 2017
The UNCCN Cancer Network is excited to announce that Dr. Trevor Hackman, Dr. Samip Patel, and Dr. Ricardo Padilla will be presenting a special online lecture on December 8, 2017, from 12 PM - 1 PM titled Oral Cancer: A Comprehensive Overview.
From the Telehealth Director
Though it seemed like it would never happen, fall colors are finally appearing, and leaves are really starting to come down. With autumn in full motion, there is plenty of excitement here at the UNC Cancer Network. I hope that you find this information informative, and we always appreciate your feedback and questions.